GO:0044313 protein K6-linked deubiquitination: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044313 (protein K6-linked deubiquitination) describes the enzymatic removal of K6-linked polyubiquitin chains from substrate proteins.
• The best-characterized reaction is USP8-mediated cleavage of K6-linked ubiquitin conjugates from parkin, a step that restrains parkin-driven mitophagy.
• K6-linked ubiquitin chains are structurally distinct and are recognized with high specificity by dedicated deubiquitinases such as LotA and Legionella ovarian tumor (Lot) DUBs.
• Dysregulation of K6-linked deubiquitination alters mitochondrial quality control and is mechanistically linked to Parkinson's disease biology.
• K6-linkage-specific DUBs are found across evolution, including bacterial effectors and apicomplexan parasites, making them attractive comparative and therapeutic targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are the core tools for dissecting K6-linked deubiquitination in cells.
Description
Protein K6-linked deubiquitination (GO:0044313) is the biological process in which a deubiquitinating enzyme (DUB) cleaves and removes a polyubiquitin chain assembled through isopeptide bonds at lysine 6 (K6) of ubiquitin monomers from a target protein. Ubiquitin chains are not uniform: the linkage position dictates chain topology, recognition by ubiquitin-binding domains, and downstream fate, and K6-linked chains represent a distinct class whose removal is catalyzed by specialized DUBs. The process is therefore a node of post-translational control that can reverse or reshape ubiquitin-dependent signaling rather than simply degrade a substrate. The prototype reaction is the USP8-dependent removal of K6-linked ubiquitin conjugates from parkin, which opposes parkin activation and mitophagy. Structural and biochemical work on bacterial effectors such as LotA and Legionella ovarian tumor DUBs has revealed how K6-linkage specificity is achieved at the active site, providing a mechanistic framework that applies to eukaryotic enzymes. Because K6-linked deubiquitination sits at the intersection of mitochondrial quality control, innate immune effector biology, and parasite biology, it is relevant to neurodegeneration, host-pathogen interactions, and drug discovery. For researchers, GO:0044313 is best studied as a reaction with defined enzyme, substrate, and chain-linkage requirements, and it is experimentally tractable using CRISPR-engineered cell models coupled to ubiquitin-chain diagnostics. This article summarizes the QuickGO definition, the molecular mechanism, the key genes, disease links, and the model systems and methods used to interrogate K6-linked deubiquitination.
protein K6-linked deubiquitination At A Glance
| GO ID | GO:0044313 |
|---|---|
| GO term | protein K6-linked deubiquitination |
| Ontology | biological_process |
| Synonym | none |
| Definition | A protein deubiquitination process in which a K6-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 6 of the ubiquitin monomers, is removed from a protein. |
| Major function | Reversal of K6-linked polyubiquitin modification on substrate proteins by DUBs such as USP8 |
| Representative substrate | parkin (PARK2), whose K6-linked ubiquitin conjugates are removed by USP8 |
| Representative enzymes | USP8 in eukaryotes; LotA and Legionella ovarian tumor DUBs in bacteria |
| Associated biology | Mitophagy regulation and mitochondrial quality control |
What Is GO:0044313?
GO:0044313 is defined as a protein deubiquitination process in which a K6-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 6 of the ubiquitin monomers, is removed from a protein. In practical terms, a DUB recognizes a substrate bearing a K6-linked polyubiquitin modification and hydrolyzes the isopeptide bond, releasing free ubiquitin or shorter chains and restoring the unmodified or differently modified substrate.
Why Is protein K6-linked deubiquitination Important in Cell Biology?
K6-linked deubiquitination is important because it provides a reversible switch on ubiquitin-chain signaling that is distinct from K48- or K63-linked editing, and it directly controls the activation state of parkin, a central regulator of mitophagy. Because mitophagy failure is implicated in Parkinson's disease and other neurodegenerative conditions, enzymes that remove K6-linked chains are candidate modulators of neuronal survival. The same chemistry is exploited by bacterial pathogens that inject K6-linkage-specific DUBs into host cells, and by apicomplexan parasites that encode OTU-family DUBs, making GO:0044313 relevant to infection biology and to the design of linkage-selective inhibitors.
• Defines a linkage-selective deubiquitination reaction that reverses K6-linked polyubiquitin on substrate proteins.
• Controls parkin activation and thereby the initiation of mitophagy.
• Links ubiquitin chain editing to mitochondrial quality control and neuronal homeostasis.
• Provides a mechanism by which bacterial effectors such as LotA manipulate host ubiquitin signaling.
• Highlights K6-linkage specificity as a structural problem in enzyme active-site recognition.
• Extends to parasite biology through OTU DUBs in Eimeria tenella.
• Offers a target class for linkage-selective DUB inhibitors in neurodegeneration and infection.
• Requires careful chain-linkage diagnostics because K6 chains are a minor but functionally distinct ubiquitin pool.
What Happens During protein K6-linked deubiquitination?
Substrate recognition and K6-chain engagement
In simple terms: The enzyme first finds and binds the protein carrying the K6-linked ubiquitin chain.
The reaction begins when a DUB engages a substrate bearing K6-linked polyubiquitin. USP8 recognizes parkin conjugated with K6-linked ubiquitin and acts on these conjugates, indicating that substrate and chain features together determine recruitment. Structural studies of the Legionella effector LotA show that K6-linked chains are bound in a defined conformation that positions the linkage for catalysis, explaining how specificity for K6 over other linkages is achieved. Related Legionella ovarian tumor DUBs likewise display linkage-dependent chain cleavage, supporting the view that chain recognition is an active, structure-encoded step.
Catalytic cleavage of the K6 isopeptide bond
In simple terms: The enzyme cuts the chemical bond that holds the ubiquitin chain together.
Once engaged, the DUB active site hydrolyzes the isopeptide bond that connects the C-terminus of one ubiquitin to lysine 6 of the next, releasing ubiquitin or shorter chains from the substrate. The catalytic mechanism is conserved among OTU-family and USP-family DUBs, but the geometry of the S1 and S1' pockets determines which linkage is preferred, and LotA provides a detailed example of K6 polyubiquitin specificity. Legionella ovarian tumor DUBs further illustrate how active-site architecture dictates chain cleavage patterns.
Reversal of parkin ubiquitination and mitophagy control
In simple terms: Removing the K6 chain changes what parkin can do, which affects how cells recycle mitochondria.
The best-characterized physiological outcome of K6-linked deubiquitination is the USP8-mediated removal of K6-linked ubiquitin conjugates from parkin, which counteracts parkin activation and restrains mitophagy. This places K6-linked deubiquitination as a negative regulatory counterweight to PINK1-parkin signaling, and it explains why DUBs are described as counteracting parkin for efficient mitophagy. The three 'P's framework (PARKIN, PINK1, and post-translational modifications) situates K6-linked deubiquitination within the broader post-translational control of mitophagy.
Downstream consequences for mitochondrial and cellular homeostasis
In simple terms: The edit changes the cell's ability to clear damaged mitochondria and to respond to stress.
Because parkin-dependent mitophagy is a mitochondrial quality-control pathway, altered K6-linked deubiquitination can shift the balance between mitochondrial retention and clearance. USP8 and PARK2/parkin-mediated mitophagy are functionally connected, and USP8 activity on K6-linked conjugates modulates this axis. In parallel, pathogen-encoded K6-selective DUBs such as LotA and Legionella ovarian tumor DUBs can remodel host ubiquitin chains during infection, showing that the downstream consequences of K6-linked deubiquitination extend beyond mitochondrial biology. In apicomplexan parasites, an Eimeria tenella OTU DUB interacts with a viral RNA-dependent RNA polymerase, indicating that K6-linked deubiquitination-like OTU activity can intersect with host or viral machinery.
Key Genes Involved in GO:0044313 protein K6-linked deubiquitination
The following genes and proteins are experimentally implicated in K6-linked deubiquitination or in the pathways it controls, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| USP8 | DUB that removes K6-linked ubiquitin conjugates from parkin | Core enzyme for GO:0044313; knockout and point-mutation models test its role in mitophagy |
| PARK2 (parkin) | Substrate whose K6-linked ubiquitination is reversed by USP8 | Central to PINK1-parkin mitophagy and Parkinson's disease models |
| PINK1 | Upstream kinase in the parkin mitophagy pathway | Defines the signaling context in which K6-linked deubiquitination acts |
| LotA | Legionella effector DUB with K6 polyubiquitin specificity | Structural model for linkage-selective K6 chain cleavage |
| Legionella ovarian tumor DUBs | Bacterial DUBs that cleave ubiquitin chains in a linkage-dependent manner | Comparative framework for K6-linkage recognition |
| Eimeria tenella OTU DUB | OTU-family DUB that interacts with Eimeria tenella virus RDRP | Parasite model linking OTU DUB activity to virus-host interactions |
| CCT3 | Chaperonin subunit implicated in ferroptosis protection via the CCT3/ACTN4/TFRC axis | Context for ubiquitin-dependent stress and iron-handling studies |
| ACTN4 | Cytoskeletal protein in the CCT3/ACTN4/TFRC axis | Relevant to cellular stress and endocytosis models |
| TFRC | Transferrin receptor controlling iron endocytosis | Links ubiquitin-related stress responses to iron uptake |
| Ubiquitin (UBB/UBC) | Polymer building block whose K6 residue forms the linkage | Source of K6-linked chains used as substrates in assays |
| ATG proteins (autophagy machinery) | Downstream effectors of mitophagy | Readout of parkin-dependent mitophagy after K6 deubiquitination |
| Mitochondrial outer membrane proteins | Targets of parkin ubiquitination in mitophagy | Substrates whose ubiquitination state is monitored |
| Proteasome-associated DUBs | General DUB machinery that can be compared with K6-selective enzymes | Specificity controls in DUB assays |
| Bacterial effector DUBs (family) | Pathogen-encoded enzymes that edit host ubiquitin chains | Tool compounds and structural templates |
| OTU-family DUBs | Enzyme family containing K6-linkage-capable members | Family-wide comparison of linkage specificity |
| PINK1-parkin pathway components | Signaling module controlling mitophagy | Genetic background for K6 deubiquitination studies |
How Is protein K6-linked deubiquitination Regulated?
K6-linked deubiquitination is regulated at the level of enzyme availability, substrate modification state, and pathway context. USP8 activity toward K6-linked parkin conjugates is positioned as a counter-regulatory step in parkin-mediated mitophagy, so the balance between parkin activation and USP8-mediated chain removal determines the mitophagy outcome. The broader PINK1-parkin post-translational modification network, including phosphorylation and ubiquitination events, sets the conditions under which K6-linked deubiquitination occurs. In bacterial systems, effector DUB activity is controlled by the enzyme's intrinsic linkage specificity and active-site architecture rather than by a canonical eukaryotic regulatory circuit, as shown for LotA and Legionella ovarian tumor DUBs. In parasites, OTU DUB interaction with viral RDRP suggests that K6-linked deubiquitination-like activity can be modulated by virus-encoded proteins.
protein K6-linked deubiquitination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| USP8 | Parkinson's disease-related mitophagy control | USP8 knockout and point-mutation cell lines with parkin readouts |
| PARK2 (parkin) | Mitophagy and neurodegeneration | Parkin knock-in and KO neurons or cell lines |
| PINK1 | Mitochondrial quality control in Parkinson's disease | PINK1 KO cells for pathway epistasis |
| LotA | Legionella infection and host ubiquitin manipulation | Bacterial effector overexpression in host cells |
| Eimeria tenella OTU DUB | Parasite-virus interaction | Parasite OTU DUB expression and interaction assays |
Parkinson's disease and neurodegeneration
USP8 removes K6-linked ubiquitin conjugates from parkin, and this reaction opposes parkin-mediated mitophagy. Because parkin and PINK1 are genetically linked to early-onset Parkinson's disease and to mitochondrial quality control in neurons, altered K6-linked deubiquitination is mechanistically relevant to neurodegeneration. Experimental models that manipulate USP8 or parkin activity are therefore used to test whether K6-linked deubiquitination modulates neuronal mitochondrial homeostasis.
Bacterial infection and host ubiquitin manipulation
Legionella pneumophila encodes LotA, a DUB with K6 polyubiquitin specificity, and related Legionella ovarian tumor DUBs cleave ubiquitin chains in a linkage-dependent manner. These enzymes allow the pathogen to edit host ubiquitin signals, so K6-linked deubiquitination is directly relevant to host-pathogen interaction and to the study of bacterial effector biology.
Parasitic and viral co-infection biology
An OTU deubiquitinating enzyme from Eimeria tenella interacts with the Eimeria tenella virus RNA-dependent RNA polymerase, linking OTU-family DUB activity to parasite-virus biology. This expands the disease relevance of K6-linked deubiquitination-like chemistry beyond metazoan mitophagy into apicomplexan infection models.
Cellular stress, ferroptosis, and iron handling
The CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis, illustrating how ubiquitin-dependent stress pathways and membrane trafficking intersect with cell-death control. Although this axis is not itself a K6-linked deubiquitination reaction, it provides a disease-relevant context in which ubiquitin editing and stress responses are studied in cancer cells.
From protein K6-linked deubiquitination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a DUB alter K6-linked ubiquitin conjugates on parkin? | CRISPR knockout of the DUB gene with anti-K6 ubiquitin immunoblotting |
| Is a catalytic residue required for K6-linked deubiquitination? | Point-mutation knock-in of the catalytic cysteine or other active-site residue |
| Does a disease-associated variant change K6-chain editing? | Knock-in of the patient variant and linkage-specific ubiquitin assays |
| Where does the DUB act in cells? | Tagged knock-in with fluorescent or affinity tag for imaging and proteomics |
| Does excess DUB activity suppress mitophagy? | Overexpression of wild-type versus catalytically dead DUB |
| Is K6-linkage specificity conserved across species? | Expression of bacterial or parasite DUBs in mammalian cells |
How to Study the protein K6-linked deubiquitination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Anti-K6 ubiquitin immunoblotting | Levels of K6-linked ubiquitin conjugates on a substrate | Testing DUB knockout or overexpression effects |
| Linkage-specific ubiquitin chains in vitro | Cleavage preference of a DUB for K6 versus other linkages | Enzyme specificity profiling |
| Mitophagy flux assays | Parkin-dependent mitochondrial clearance | Functional consequence of K6 deubiquitination |
| Ubiquitin remnant mass spectrometry | Site-specific ubiquitination changes | Global substrate mapping after DUB perturbation |
| Crystallography and kinetics | Active-site recognition of K6 chains | Mechanistic and inhibitor studies |
| Fluorescence imaging of tagged DUB | Subcellular localization and substrate colocalization | Spatial dissection of the reaction |
| Interaction proteomics | Binding partners of DUBs and substrates | Identifying regulatory complexes |
| CRISPR perturbation screens | Genetic dependencies of K6-linked deubiquitination phenotypes | Candidate gene discovery in mitophagy pathways |
Linkage-specific ubiquitin diagnostics
Because GO:0044313 is defined by K6 linkage, assays must distinguish K6-linked chains from K48- or K63-linked chains. Anti-K6 ubiquitin reagents and linkage-specific chain binders are used to monitor the removal of K6 conjugates from substrates such as parkin after DUB manipulation. Structural and biochemical assays with defined K6-linked ubiquitin chains provide the specificity controls needed to interpret these results.
Mitophagy and mitochondrial function assays
Since USP8-mediated K6-linked deubiquitination controls parkin-dependent mitophagy, mitochondrial readouts are central methods. These include monitoring mitochondrial clearance, mitochondrial membrane potential, and parkin recruitment in cells with altered DUB or parkin activity, within the PINK1-parkin post-translational framework.
Proteomics and ubiquitin remnant profiling
Mass spectrometry-based ubiquitin remnant profiling can quantify site-specific ubiquitination changes after DUB perturbation, allowing researchers to ask whether K6-linked deubiquitination reshapes the ubiquitin landscape on specific substrates. Comparative proteomics between wild-type and catalytic-dead DUB cells helps separate catalytic from scaffolding effects.
Structural and enzymology approaches
Crystal structures and kinetic assays of K6-selective DUBs such as LotA and Legionella ovarian tumor DUBs reveal how active-site pockets discriminate K6 chains from other linkages. These methods provide the mechanistic basis for designing linkage-selective inhibitors and for interpreting cellular results.
How CRISPR Can Be Used to Study GO:0044313 protein K6-linked deubiquitination
Knockout
CRISPR knockout of a candidate DUB such as USP8 removes the enzyme and allows direct testing of whether K6-linked ubiquitin conjugates accumulate on substrates like parkin. Knockout cells are also used to test epistasis with parkin and PINK1 in mitophagy assays.
Point Mutation
Point-mutation knock-in of catalytic residues distinguishes enzymatic activity from scaffolding functions, which is essential for DUBs whose K6-linkage specificity depends on precise active-site geometry. Catalytically dead mutants are the standard control for K6-linked deubiquitination experiments.
Knock-in
Tagged or disease-variant knock-in models allow endogenous-level expression of the DUB or its substrate, enabling imaging, affinity purification, and linkage-specific ubiquitin analysis without overexpression artifacts. Knock-in of patient variants can test whether a mutation alters K6-chain editing.
Overexpression
Overexpression of wild-type versus catalytically inactive DUBs is used to test sufficiency for removing K6-linked chains and for suppressing mitophagy. Overexpression of bacterial or parasite DUBs in mammalian cells tests conservation of K6-linkage specificity across species.
How EDITGENE Supports protein K6-linked deubiquitination Research
Researchers studying protein K6-linked deubiquitination-related genes often need to determine whether a candidate gene is causally involved in K6-chain removal, substrate stabilization, or downstream mitophagy control. Answering that question requires clean genetic models in which the DUB, its substrate, or its catalytic residue is precisely altered, coupled to linkage-specific ubiquitin readouts. EDITGENE provides the CRISPR-engineered cell models and screening services needed to move from correlation to causation in this pathway.
Contact EDITGENE today to design your custom CRISPR model for protein K6-linked deubiquitination research.
Frequently Asked Questions About protein K6-linked deubiquitination
What is protein K6-linked deubiquitination?
It is the biological process GO:0044313 in which a K6-linked ubiquitin chain, formed by linkages at lysine 6 of ubiquitin monomers, is removed from a protein by a deubiquitinating enzyme.
What genes are involved in protein K6-linked deubiquitination?
The best-characterized gene is USP8, which removes K6-linked ubiquitin conjugates from parkin, and the substrate gene is PARK2 (parkin); bacterial effectors such as LotA and Legionella ovarian tumor DUBs also carry out K6-linkage-specific cleavage.
Which enzyme removes K6-linked ubiquitin from parkin?
USP8 removes K6-linked ubiquitin conjugates from parkin and thereby regulates mitophagy.
Why is K6-linked deubiquitination important for mitophagy?
Because removing K6-linked chains from parkin counteracts parkin activation, DUBs act as a brake on parkin-dependent mitophagy.
Is K6-linked deubiquitination conserved in bacteria?
Yes, Legionella pneumophila LotA is a deubiquitinase with K6 polyubiquitin specificity, and related Legionella ovarian tumor DUBs cleave ubiquitin chains in a linkage-dependent manner.
How is K6-linked deubiquitination studied experimentally?
Researchers use linkage-specific ubiquitin diagnostics, mitophagy flux assays, ubiquitin remnant mass spectrometry, and structural enzymology, often in CRISPR-engineered cells.
What diseases are linked to K6-linked deubiquitination?
The pathway is linked to Parkinson's disease biology through parkin and mitophagy, and to bacterial infection through pathogen-encoded K6-selective DUBs.
What is the GO ID for protein K6-linked deubiquitination?
The GO ID is GO:0044313, a biological_process term.
Does K6-linked deubiquitination occur in parasites?
An OTU deubiquitinating enzyme from Eimeria tenella interacts with the Eimeria tenella virus RNA-dependent RNA polymerase, indicating OTU DUB activity in parasite biology.
What CRISPR models are used to study K6-linked deubiquitination?
Knockout, point-mutation, knock-in, and overexpression models of DUBs and substrates are used to test causality and catalytic requirement in K6-linked deubiquitination.
Conclusion
GO:0044313, protein K6-linked deubiquitination, is a linkage-selective deubiquitination process whose prototype is USP8-mediated removal of K6-linked ubiquitin conjugates from parkin, a reaction that restrains parkin-dependent mitophagy. The process is mechanistically defined by the ability of DUBs such as LotA and Legionella ovarian tumor enzymes to recognize K6-linked chains with high specificity, a property encoded in active-site architecture. Its relevance spans neurodegeneration, host-pathogen interaction, and parasite biology, making it a compelling target for functional genomics. Because K6-linked deubiquitination is a reversible enzymatic reaction, causal questions are best addressed with precise CRISPR models coupled to linkage-specific ubiquitin and mitophagy readouts. EDITGENE supports this workflow with knockout, point-mutation, knock-in, overexpression, and CRISPR screening services tailored to K6-linked deubiquitination research.
References
- 1. Zhu H et al.. 2024. CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis.. J Exp Clin Cancer Res 43(1):245 PMID: 39210442
- 2. Durcan TM et al.. 2015. USP8 and PARK2/parkin-mediated mitophagy.. Autophagy 11(2):428-9 PMID: 25700639
- 3. Durcan TM et al.. 2014. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin.. EMBO J 33(21):2473-91 PMID: 25216678
- 4. Warren GD et al.. 2023. Mechanism of Lys6 poly-ubiquitin specificity by the L. pneumophila deubiquitinase LotA.. Mol Cell 83(1):105-120.e5 PMID: 36538933
- 5. Durcan TM et al.. 2015. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.. Genes Dev 29(10):989-99 PMID: 25995186
- 6. Dikic I et al.. 2014. DUBs counteract parkin for efficient mitophagy.. EMBO J 33(21):2442-3 PMID: 25274967
- 7. Kang S et al.. 2023. Structural insights into ubiquitin chain cleavage by Legionella ovarian tumor deubiquitinases.. Life Sci Alliance 6(7) PMID: 37100438
- 8. Wang P et al.. 2018. An OTU deubiquitinating enzyme in Eimeria tenella interacts with Eimeria tenella virus RDRP.. Parasit Vectors 11(1):74 PMID: 29386062
